Xtant Medical
XTNT

股本结构

单位：万股
公告日期 2026-03-31 2026-03-31 2025-11-10 2025-09-15 2025-08-12 2025-08-12
证券总股本 14006.83 14003.96 14000.42 14000.05 13031.57 13931.57
普通股本 14006.83 14003.96 14000.42 14000.05 13031.57 13931.57
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2026-03-25 2025-12-31 2025-09-30 2025-09-09 2025-08-08 2025-06-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2026-03-31 14006.83 未披露 定期报告 2026-03-25
2026-03-31 14003.96 未披露
更多>>
From December 31, 2024 to December 31, 2025 Common stock issued upon vesting and settlement of restricted stock units Withholding on common stock upon vesting and settlement of restricted stock units
2025-12-31
2025-11-10 14000.42 未披露
更多>>
From June 30, 2025 to September 30, 2025 Common stock issued upon settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
2025-09-30
2025-09-15 14000.05 未披露 定期报告 2025-09-09
2025-08-12 13031.57 未披露 定期报告 2025-08-08
2025-08-12 13931.57 未披露
更多>>
From March 31, 2025 to June 30, 2025 Common stock issued upon settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
2025-06-30
2025-05-12 13932.32 未披露 定期报告 2025-05-08
2025-04-16 13930.89 未披露 定期报告 2025-04-15
2025-05-12 13908.22 未披露
更多>>
From December 31, 2024 to March 31, 2025 Common stock issued on settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
2025-03-31
2025-03-06 13906.79 未披露 定期报告 2025-02-28
2025-03-06 13904.57 未披露
更多>>
From December 31, 2023 to December 31, 2024 Withholding on common stock upon vesting and settlement of restricted stock units Common stock issued upon vesting and settlement of restricted stock units Private placement of common stock, net of issuance costs of $544 Exercise of stock options
2024-12-31
2024-11-12 13900.85 未披露 定期报告 2024-11-07
2024-11-12 13868.09 未披露
更多>>
From June 30, 2024 to September 30, 2024 Private placement of common stock, net of issuance costs of $191 Exercise of stock options Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
2024-09-30
2024-09-03 13871.04 未披露 定期报告 2024-08-28
2024-08-08 13812.69 未披露
更多>>
On August 8, 2024 the company issued 7,812,500 shares of common stock
2024-08-08
2024-08-08 13031.44 未披露
更多>>
From March 31, 2024 to June 30, 2024 Common stock issued on vesting of restricted stock units
2024-06-30
2024-06-10 13026.86 未披露 定期报告 2024-05-28
2024-05-15 13021.65 未披露
更多>>
From December 31, 2023 to March 31, 2024 Common stock issued on vesting of restricted stock units Withholding on common stock upon vesting of restricted stock units
2024-03-31
2024-04-01 13021.65 未披露 定期报告 2024-03-25
2024-04-01 13018.00 未披露
更多>>
From December 31, 2022 to December 31, 2023 Private placement of common stock, net of issuance costs of $175 Withholding on common stock upon vesting of restricted stock units Common stock issued on vesting of restricted stock units
2023-12-31
2023-11-14 13011.03 未披露 定期报告 2023-11-13
2023-11-14 12978.89 未披露
更多>>
From June 30, 2023 to September 30, 2023 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units Private placement of common stock, net of issuance costs of $175
2023-09-30
2023-07-07 12889.70 未披露 定期报告 2023-07-06
2023-05-04 10889.70 未披露
更多>>
From December 31, 2022 to March 31, 2023 Common stock issued on vesting of restricted stock units
2023-03-31
2023-03-07 10889.70 未披露 定期报告 2023-03-03
2023-03-07 10887.48 未披露
更多>>
From December 31, 2021 to December 31, 2022 Common stock issued on vesting of restricted stock units Private placement of common stock, net of issuance costs of $436
2022-12-31
2022-11-03 10865.94 未披露 定期报告 2022-11-01
2022-10-11 10822.64 未披露 定期报告 2022-10-10
2022-11-03 10198.13 未披露
更多>>
From June 30, 2022 to September 30, 2022 Private placement of common stock, net of issuance costs of $409 Common stock issued on vesting of restricted stock units
2022-09-30
2022-09-20 10198.13 未披露 定期报告 2022-09-15
2022-08-31 10141.37 未披露
更多>>
On August 25, 2022, Xtant Medical Holdings, Inc. (the “Company”) closed the first tranche of its previously announced private placement (the “First Closing”) with several accredited investors (the “Private Placement”). At the First Closing, the Company sold approximately 14.1 million shares of common stock of the Company
2022-08-25
2022-09-09 8792.09 未披露 定期报告 2022-08-23
2022-05-05 8731.37 未披露
更多>>
From December 31, 2021 to March 31, 2022 Common stock issued on vesting of restricted stock units
2022-03-31
2022-03-08 8731.37 未披露 定期报告 2022-03-08
2022-03-08 8706.90 未披露
更多>>
From December 31, 2020 to December 31, 2021 Private placement of common stock, net of issuance costs of $1,926,000 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
2021-12-31
2021-11-12 8679.62 未披露
更多>>
From June 30, 2021 to September 30, 2021 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
2021-09-30
2021-05-11 8670.73 未披露
更多>>
From December 31, 2020 to March 31, 2021 Private placement of common stock, net of issuance costs of $1,926 Common stock issued on vesting of restricted stock units
2021-03-31
2021-04-06 8670.73 未披露 定期报告 2021-03-12
2021-02-24 7781.84 未披露 定期报告 2021-02-22
2021-02-24 7757.37 未披露
更多>>
From December 31, 2019 to December 31, 2020 Common stock issued on vesting of restricted stock units Debt exchange, net of exchange costs of $1,058 Issuance of common shares, net of issuance costs of $143 Exercise of warrants
2020-12-31
2020-12-18 7757.37 未披露 定期报告 2020-12-15
2020-10-30 7206.10 未披露 定期报告 2020-10-29
2020-10-29 7206.10 未披露 定期报告 2020-10-27
2020-10-29 1324.08 未披露
更多>>
From June 30, 2020 to September 30, 2020 Common stock issued on vesting of restricted stock units
2020-09-30
2020-09-10 1324.08 未披露 定期报告 2020-09-01
2020-08-03 1322.36 未披露 定期报告 2020-06-30
2020-05-07 1322.36 未披露
更多>>
From December 31, 2019 to March 05, 2020 Common stock issued on vesting of restricted stock units
2020-03-02
2019-05-15 1316.18 未披露
更多>>
from December 31, 2018 to March 31, 2019 Forfeiture of restricted stock
2019-03-31
2019-04-01 1316.18 未披露 定期报告 2019-03-29
2019-04-01 1317.22 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common stock
2018-12-31
2018-11-14 1317.13 未披露 定期报告 2018-09-30
2018-08-08 1314.53 未披露 定期报告 2018-06-30
2018-06-26 1314.52 未披露 定期报告 2018-06-15
2018-05-08 1307.75 未披露 定期报告 2018-03-31
2018-02-13 170.45 未披露
更多>>
On February 13, 2018, following the Special Meeting, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate Amendment”) to effect a reverse stock split of the Common Stock at a ratio of 1:12.The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on February 13, 2018, and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on February 14, 2018.
2018-02-14
2018-01-22 2045.45 未披露 定期报告 2018-01-18
2018-04-02 1817.88 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of restricted stock Issuance of common stock
2017-12-31
2017-11-21 1817.30 未披露 定期报告 2017-09-30
2017-05-15 1809.26 未披露 定期报告 2017-03-31
2017-03-29 1809.26 未披露 定期报告 2017-03-29
2017-03-29 1724.93 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of restricted stock Issuance of common stock Net proceeds from the issuance of stock rights Issuance of stock to Aspire Capital
2016-12-31
2016-11-10 1219.40 未披露 定期报告 2016-09-30
2016-08-10 1219.40 未披露 定期报告 2016-08-04
2016-08-10 1213.52 未披露 定期报告 2016-06-30
2016-06-08 1213.52 未披露 定期报告 2016-04-30
2016-03-24 1189.76 未披露
更多>>
from December 31, 2014 to December 31, 2015 Issuance of restricted stock Issuance of common stock Net proceeds from the issuance of stock Issuance of stock related to acquisition Issuance of stock to Aspire Capital
2015-12-31
2015-12-21 1188.61 未披露 定期报告 2015-11-30
2015-10-19 1188.61 未披露 定期报告 2015-10-19
2015-11-16 1188.61 未披露 定期报告 2015-09-30
2015-08-14 1174.61 未披露 定期报告 2015-08-06
2015-08-14 746.41 未披露 定期报告 2015-06-30
2015-05-05 704.44 未披露 定期报告 2015-03-31
2015-03-18 668.31 未披露 定期报告 2015-03-10
2015-03-18 667.96 未披露
更多>>
From December 31,2013 to December 31,2014 Stock-based compensation Net proceeds from the issuance of stock Issuance of stock to ROS to amend Credit Agreement to borrow additional $4 million The Company completed a 1:10 reverse split of its common stock, effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014
2014-12-31
2014-11-07 667.51 未披露 定期报告 2014-11-03
2014-11-05 668.46 未披露 定期报告 2014-09-30
2014-08-14 666.99 未披露 定期报告 2014-08-11
2014-08-14 553.29 未披露
更多>>
The Company completed a 1:10 reverse split of its common stock, effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014
2014-07-28
2014-05-12 5497.56 未披露 定期报告 2014-04-17
2014-05-06 5498.21 未披露 定期报告 2014-03-31
2014-04-01 5485.85 未披露 定期报告 2014-03-28
2014-03-27 5485.85 未披露 定期报告 2014-03-12
2014-03-27 5343.28 未披露
更多>>
From December 31,2012 to December 31,2013 Stock-based compensation Exercise of options Net proceeds from the issuance of stock Issuance of stock to ROS in exchange for debt waiver
2013-12-31
2013-11-14 5174.41 未披露 定期报告 2013-11-13
2013-11-07 5178.10 未披露 定期报告 2013-09-30
2013-08-13 5136.70 未披露 定期报告 2013-08-01
2013-08-07 5152.85 未披露 定期报告 2013-06-30
2013-06-14 4282.20 未披露 定期报告 2013-05-31
2013-05-10 4276.26 未披露 定期报告 2013-04-25
2013-05-10 4295.78 未披露 定期报告 2013-03-31
2013-03-27 4265.00 未披露 定期报告 2013-03-05
2013-03-27 4287.78 未披露
更多>>
from December 31, 2011 to December 31, 2012 Stock-based compensation Exercise of options Exercise of warrants Private placement
2012-12-31
2012-11-08 4260.08 未披露 定期报告 2012-10-24
2012-11-07 4286.43 未披露 定期报告 2012-09-30
2012-08-10 4244.90 未披露 定期报告 2012-07-26
2012-08-10 4274.75 未披露 定期报告 2012-06-30
2012-06-28 4244.90 未披露 定期报告 2012-06-08
2012-05-04 4242.57 未披露 定期报告 2012-04-12
2012-05-03 4252.41 未披露 定期报告 2012-03-31
2012-03-29 4207.66 未披露 定期报告 2012-03-13
2012-03-29 4084.12 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Private placement Exercise of warrants Stock grants Stock-based compensation Exercise of options Acquisition of RMS
2011-12-31
2011-11-14 4059.46 未披露 定期报告 2011-11-07
2011-11-14 4015.80 未披露 定期报告 2011-09-30
2011-08-15 3964.56 未披露 定期报告 2011-08-09
2011-08-11 3885.89 未披露 定期报告 2011-06-30
2011-05-12 3807.69 未披露 定期报告 2011-05-11
2011-05-12 3767.73 未披露 定期报告 2011-03-31
2011-04-11 3765.94 未披露 定期报告 2011-03-17
2011-04-11 3699.47 未披露
更多>>
from Dec 31 2009 to Dec 31 2010 Private placement Conversion of notes to common stock Conversion of bridge notes to common stock Placement agent shares Sale of common stock Retirement of treasury stock Exercise of warrants-warrant exchange program Cashless exercise of warrants Stock-based compensation Warrants/shares issued in legal settlement Exercise of options Reverse merger transactions
2010-12-31
2010-11-16 3590.02 未披露 定期报告 2010-11-12
2010-11-16 3590.39 未披露 定期报告 2010-09-30
2010-08-20 3555.89 未披露 定期报告 2010-08-13
2010-08-20 3443.43 未披露 定期报告 2010-06-30
2010-05-12 450.00 未披露 定期报告 2010-05-12
2010-05-12 550.00 未披露 定期报告 2010-03-31
From December 31, 2024 to December 31, 2025 Common stock issued upon vesting and settlement of restricted stock units Withholding on common stock upon vesting and settlement of restricted stock units
From June 30, 2025 to September 30, 2025 Common stock issued upon settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
From March 31, 2025 to June 30, 2025 Common stock issued upon settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
From December 31, 2024 to March 31, 2025 Common stock issued on settlement of restricted stock units Withholding of common stock upon settlement of restricted stock units
From December 31, 2023 to December 31, 2024 Withholding on common stock upon vesting and settlement of restricted stock units Common stock issued upon vesting and settlement of restricted stock units Private placement of common stock, net of issuance costs of $544 Exercise of stock options
From June 30, 2024 to September 30, 2024 Private placement of common stock, net of issuance costs of $191 Exercise of stock options Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
On August 8, 2024 the company issued 7,812,500 shares of common stock
From March 31, 2024 to June 30, 2024 Common stock issued on vesting of restricted stock units
From December 31, 2023 to March 31, 2024 Common stock issued on vesting of restricted stock units Withholding on common stock upon vesting of restricted stock units
From December 31, 2022 to December 31, 2023 Private placement of common stock, net of issuance costs of $175 Withholding on common stock upon vesting of restricted stock units Common stock issued on vesting of restricted stock units
From June 30, 2023 to September 30, 2023 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units Private placement of common stock, net of issuance costs of $175
From December 31, 2022 to March 31, 2023 Common stock issued on vesting of restricted stock units
From December 31, 2021 to December 31, 2022 Common stock issued on vesting of restricted stock units Private placement of common stock, net of issuance costs of $436
From June 30, 2022 to September 30, 2022 Private placement of common stock, net of issuance costs of $409 Common stock issued on vesting of restricted stock units
On August 25, 2022, Xtant Medical Holdings, Inc. (the “Company”) closed the first tranche of its previously announced private placement (the “First Closing”) with several accredited investors (the “Private Placement”). At the First Closing, the Company sold approximately 14.1 million shares of common stock of the Company
From December 31, 2021 to March 31, 2022 Common stock issued on vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Private placement of common stock, net of issuance costs of $1,926,000 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
From June 30, 2021 to September 30, 2021 Common stock issued on vesting of restricted stock units Withholding of common stock upon vesting of restricted stock units
From December 31, 2020 to March 31, 2021 Private placement of common stock, net of issuance costs of $1,926 Common stock issued on vesting of restricted stock units
From December 31, 2019 to December 31, 2020 Common stock issued on vesting of restricted stock units Debt exchange, net of exchange costs of $1,058 Issuance of common shares, net of issuance costs of $143 Exercise of warrants
From June 30, 2020 to September 30, 2020 Common stock issued on vesting of restricted stock units
From December 31, 2019 to March 05, 2020 Common stock issued on vesting of restricted stock units
from December 31, 2018 to March 31, 2019 Forfeiture of restricted stock
from December 31, 2017 to December 31, 2018 Issuance of common stock
On February 13, 2018, following the Special Meeting, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate Amendment”) to effect a reverse stock split of the Common Stock at a ratio of 1:12.The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on February 13, 2018, and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on February 14, 2018.
from December 31, 2016 to December 31, 2017 Issuance of restricted stock Issuance of common stock
from December 31, 2015 to December 31, 2016 Issuance of restricted stock Issuance of common stock Net proceeds from the issuance of stock rights Issuance of stock to Aspire Capital
from December 31, 2014 to December 31, 2015 Issuance of restricted stock Issuance of common stock Net proceeds from the issuance of stock Issuance of stock related to acquisition Issuance of stock to Aspire Capital
From December 31,2013 to December 31,2014 Stock-based compensation Net proceeds from the issuance of stock Issuance of stock to ROS to amend Credit Agreement to borrow additional $4 million The Company completed a 1:10 reverse split of its common stock, effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014
The Company completed a 1:10 reverse split of its common stock, effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014
From December 31,2012 to December 31,2013 Stock-based compensation Exercise of options Net proceeds from the issuance of stock Issuance of stock to ROS in exchange for debt waiver
from December 31, 2011 to December 31, 2012 Stock-based compensation Exercise of options Exercise of warrants Private placement
from Dec 31,2010 to Dec 31,2011 Private placement Exercise of warrants Stock grants Stock-based compensation Exercise of options Acquisition of RMS
from Dec 31 2009 to Dec 31 2010 Private placement Conversion of notes to common stock Conversion of bridge notes to common stock Placement agent shares Sale of common stock Retirement of treasury stock Exercise of warrants-warrant exchange program Cashless exercise of warrants Stock-based compensation Warrants/shares issued in legal settlement Exercise of options Reverse merger transactions
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。